
The FDA has now approved Cymbalta (duloxetine) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain.
"Up to three quarters of the population experience chronic pain at some time in their lives," said Janet Woodcock, M.D., director of FDA's Center for Drug Evaluation and Research. "This approval means that many of those people now have another treatment option."
Since its initial approval in 2004, about 30 million patients in the United...
